Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes.

Ragulan C, Eason K, Fontana E, Nyamundanda G, Tarazona N, Patil Y, Poudel P, Lawlor RT, Del Rio M, Koo SL, Tan WS, Sclafani F, Begum R, Teixeira Mendes LS, Martineau P, Scarpa A, Cervantes A, Tan IB, Cunningham D, Sadanandam A.

Sci Rep. 2019 May 21;9(1):7665. doi: 10.1038/s41598-019-43492-0.

2.

Improving tumor budding evaluation in colon cancer by extending the assessment area in colectomy specimen.

Martinez-Ciarpaglini C, Fernandez-Sellers C, Tarazona N, Roselló S, Huerta M, Roda D, Mongort C, Ferrández A, Navarro S, Cervantes A.

Histopathology. 2019 May 13. doi: 10.1111/his.13900. [Epub ahead of print]

PMID:
31081121
3.

Towards precision oncology for anti-HER2 blockade in gastroesophageal adenocarcinoma.

Gambardella V, Fleitas T, Tarazona N, Cejalvo JM, Gimeno-Valiente F, Martinez-Ciarpaglini C, Huerta M, Roselló S, Castillo J, Roda D, Cervantes A.

Ann Oncol. 2019 May 2. pii: mdz143. doi: 10.1093/annonc/mdz143. [Epub ahead of print]

PMID:
31046106
4.

Molecular Insights into the Physical Adsorption of Amphiphilic Protein PhaF onto Copolyester Surfaces.

Tarazona NA, Machatschek R, Schulz B, Prieto MA, Lendlein A.

Biomacromolecules. 2019 Apr 29. doi: 10.1021/acs.biomac.9b00069. [Epub ahead of print]

PMID:
30990311
5.

Interfacial Activity of Phasin PhaF from Pseudomonas putida KT2440 at Hydrophobic-Hydrophilic Biointerfaces.

Mato A, Tarazona NA, Hidalgo A, Cruz A, Jiménez M, Pérez-Gil J, Prieto MA.

Langmuir. 2019 Jan 22;35(3):678-686. doi: 10.1021/acs.langmuir.8b03036. Epub 2019 Jan 9.

PMID:
30580527
6.

NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric Cancer.

Gambardella V, Gimeno-Valiente F, Tarazona N, Martinez-Ciarpaglini C, Roda D, Fleitas T, Tolosa P, Cejalvo JM, Huerta M, Roselló S, Castillo J, Cervantes A.

Clin Cancer Res. 2019 Mar 1;25(5):1639-1649. doi: 10.1158/1078-0432.CCR-18-2421. Epub 2018 Nov 30.

PMID:
30504425
7.

Role of leucine zipper-like motifs in the oligomerization of Pseudomonas putida phasins.

Tarazona NA, Maestro B, Revelles O, Sanz JM, Prieto MA.

Biochim Biophys Acta Gen Subj. 2019 Feb;1863(2):362-370. doi: 10.1016/j.bbagen.2018.11.002. Epub 2018 Nov 9.

PMID:
30419286
8.

Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression.

Martinez-Ciarpaglini C, Oltra S, Roselló S, Roda D, Mongort C, Carrasco F, Gonzalez J, Santonja F, Tarazona N, Huerta M, Espí A, Ribas G, Ferrández A, Navarro S, Cervantes A.

Mod Pathol. 2019 Feb;32(2):306-313. doi: 10.1038/s41379-018-0124-5. Epub 2018 Sep 11.

PMID:
30206410
9.

The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision.

Roselló S, Papaccio F, Roda D, Tarazona N, Cervantes A.

Cancer Treat Rev. 2018 Feb;63:156-171. doi: 10.1016/j.ctrv.2018.01.001. Epub 2018 Jan 11. Review.

PMID:
29407455
10.

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.

Sclafani F, Chau I, Cunningham D, Hahne JC, Vlachogiannis G, Eltahir Z, Lampis A, Braconi C, Kalaitzaki E, De Castro DG, Wotherspoon A, Capdevila J, Glimelius B, Tarazona N, Begum R, Lote H, Hulkki Wilson S, Mentrasti G, Brown G, Tait D, Oates J, Valeri N.

Sci Rep. 2018 Jan 23;8(1):1445. doi: 10.1038/s41598-018-19212-5.

11.

Liquid biopsy: another tool towards tailored therapy in colorectal cancer.

Tarazona N, Cervantes A.

Ann Oncol. 2018 Jan 1;29(1):7-8. doi: 10.1093/annonc/mdx641. No abstract available.

PMID:
29045545
12.

Personalised Treatment in Gastric Cancer: Myth or Reality?

Tarazona N, Gambardella V, Huerta M, Roselló S, Cervantes A.

Curr Oncol Rep. 2016 Jul;18(7):41. doi: 10.1007/s11912-016-0525-x. Review.

PMID:
27215435
13.

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial.

Pearson A, Smyth E, Babina IS, Herrera-Abreu MT, Tarazona N, Peckitt C, Kilgour E, Smith NR, Geh C, Rooney C, Cutts R, Campbell J, Ning J, Fenwick K, Swain A, Brown G, Chua S, Thomas A, Johnston SRD, Ajaz M, Sumpter K, Gillbanks A, Watkins D, Chau I, Popat S, Cunningham D, Turner NC.

Cancer Discov. 2016 Aug;6(8):838-851. doi: 10.1158/2159-8290.CD-15-1246. Epub 2016 May 13.

14.

Efficacy and toxicity of salvage weekly paclitaxel chemotherapy in non-Asian patients with advanced oesophagogastric adenocarcinoma.

Tarazona N, Smyth EC, Peckit C, Chau I, Watkins D, Rao S, Starling N, Cunningham D.

Ther Adv Med Oncol. 2016 Mar;8(2):104-12. doi: 10.1177/1758834015621669.

15.

Clinical pharmacokinetics and pharmacodynamics of ramucirumab in the treatment of colorectal cancer.

Gambardella V, Tarazona N, Cejalvo JM, Roselló S, Cervantes A.

Expert Opin Drug Metab Toxicol. 2016;12(4):449-56. doi: 10.1517/17425255.2016.1156084. Epub 2016 Mar 10. Review.

PMID:
26895445
16.

Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified?

Smyth EC, Tarazona N, Peckitt C, Armstrong E, Mansukhani S, Cunningham D, Chau I.

Clin Colorectal Cancer. 2016 Jun;15(2):e53-9. doi: 10.1016/j.clcc.2015.11.003. Epub 2015 Nov 27.

PMID:
26747392
17.

Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer.

Schiavon G, Hrebien S, Garcia-Murillas I, Cutts RJ, Pearson A, Tarazona N, Fenwick K, Kozarewa I, Lopez-Knowles E, Ribas R, Nerurkar A, Osin P, Chandarlapaty S, Martin LA, Dowsett M, Smith IE, Turner NC.

Sci Transl Med. 2015 Nov 11;7(313):313ra182. doi: 10.1126/scitranslmed.aac7551.

18.

Carbon roadmap from syngas to polyhydroxyalkanoates in Rhodospirillum rubrum.

Revelles O, Tarazona N, García JL, Prieto MA.

Environ Microbiol. 2016 Feb;18(2):708-20. doi: 10.1111/1462-2920.13087. Epub 2015 Dec 22.

19.

Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer.

Ibarrola-Villava M, Llorca-Cardeñosa MJ, Tarazona N, Mongort C, Fleitas T, Perez-Fidalgo JA, Roselló S, Navarro S, Ribas G, Cervantes A.

Oncotarget. 2015 Sep 29;6(29):26935-45. doi: 10.18632/oncotarget.4775.

20.

Primary paraesophageal Ewing's sarcoma: an uncommon case report and literature review.

Tarazona N, Navarro L, Cejalvo JM, Gambardella V, Pérez-Fidalgo JA, Sempere A, Navarro S, Cervantes A.

Onco Targets Ther. 2015 May 14;8:1053-9. doi: 10.2147/OTT.S80879. eCollection 2015.

21.

A holistic view of polyhydroxyalkanoate metabolism in Pseudomonas putida.

Prieto A, Escapa IF, Martínez V, Dinjaski N, Herencias C, de la Peña F, Tarazona N, Revelles O.

Environ Microbiol. 2016 Feb;18(2):341-57. doi: 10.1111/1462-2920.12760. Epub 2015 Feb 11. Review.

PMID:
25556983
22.

Ramucirumab: targeting angiogenesis in the treatment of gastric cancer.

Smyth EC, Tarazona N, Chau I.

Immunotherapy. 2014;6(11):1177-86. doi: 10.2217/imt.14.85. Review.

PMID:
25496333
23.

Implementation and assessment of a fast-track programme to improve communication between primary and specialized care in patients with suspected cancer: how to shorten time between initial symptoms of cancer, diagnosis and initiation of treatment.

Martínez MT, González I, Tarazona N, Roselló S, Saiz R, Sanmartín A, Martínez-Agulló Á, Caballero A, Mas P, Franco J, Martínez-Jabaloyas J, García-Callejo J, Martín V, Navarro J, Teruel A, Lluch A, Chirivella I.

Clin Transl Oncol. 2015 Feb;17(2):167-72. doi: 10.1007/s12094-014-1209-3. Epub 2014 Aug 7.

PMID:
25100066
24.

Current questions for the treatment of advanced gastric cancer.

Cervantes A, Roda D, Tarazona N, Roselló S, Pérez-Fidalgo JA.

Cancer Treat Rev. 2013 Feb;39(1):60-7. doi: 10.1016/j.ctrv.2012.09.007. Epub 2012 Oct 25. Review.

PMID:
23102520
25.

Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance.

Sanborn TA, Hackett NR, Lee LY, El-Sawy T, Blanco I, Tarazona N, Deutsch E, Crystal R, Rosengart TK.

Catheter Cardiovasc Interv. 2001 Feb;52(2):260-6.

PMID:
11170342
26.

The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance.

McCaffrey TA, Du B, Fu C, Bray PJ, Sanborn TA, Deutsch E, Tarazona N, Shaknovitch A, Newman G, Patterson C, Bush HL Jr.

J Mol Cell Cardiol. 1999 Sep;31(9):1627-42.

PMID:
10471347
27.

Novel distal occluder washout method for prevention of no-reflow during stenting of saphenous vein grafts.

Shaknovich A, Forman ST, Parikh MA, Deutsch E, Bergman GW, McCaffrey TA, Newman GC, Tarazona N, Sanborn TA.

Catheter Cardiovasc Interv. 1999 Aug;47(4):397-403.

PMID:
10470466
28.

Use of the porous balloon in porcine coronary arteries: rationale for low pressure and volume delivery.

Santoian EC, Gravanis MB, Schneider JE, Tarazona N, Cipolla GD, Robinson KA, King SB 3rd.

Cathet Cardiovasc Diagn. 1993 Dec;30(4):348-54.

PMID:
8287467
29.

Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis.

Schneider JE, Berk BC, Gravanis MB, Santoian EC, Cipolla GD, Tarazona N, Lassegue B, King SB 3rd.

Circulation. 1993 Aug;88(2):628-37.

PMID:
8339427
30.

Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries.

Santoian ED, Schneider JE, Gravanis MB, Foegh M, Tarazona N, Cipolla GD, King SB 3rd.

Circulation. 1993 Jul;88(1):11-4.

PMID:
8100489

Supplemental Content

Loading ...
Support Center